1. Home
  2. PECO vs DNTH Comparison

PECO vs DNTH Comparison

Compare PECO & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phillips Edison & Company Inc.

PECO

Phillips Edison & Company Inc.

N/A

Current Price

$40.43

Market Cap

5.2B

Sector

Real Estate

ML Signal

N/A

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$83.31

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PECO
DNTH
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.9B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
PECO
DNTH
Price
$40.43
$83.31
Analyst Decision
Buy
Strong Buy
Analyst Count
14
18
Target Price
$43.46
★ $139.25
AVG Volume (30 Days)
★ 968.8K
723.8K
Earning Date
10-26-2026
11-04-2026
Dividend Yield
★ 3.42%
N/A
EPS Growth
★ 74.51
N/A
EPS
★ 1.05
N/A
Revenue
★ $726,594,000.00
$2,036,000.00
Revenue This Year
$5.19
$22.80
Revenue Next Year
$6.41
N/A
P/E Ratio
$38.48
★ N/A
Revenue Growth
★ 9.86
N/A
52 Week Low
$34.49
$35.84
52 Week High
$44.38
$117.88

Technical Indicators

Market Signals
Indicator
PECO
DNTH
Relative Strength Index (RSI) 56.04 44.01
Support Level $38.78 $79.54
Resistance Level $40.49 $91.36
Average True Range (ATR) 0.69 4.84
MACD -0.07 -0.08
Stochastic Oscillator 42.91 19.24

Price Performance

Historical Comparison
PECO
DNTH

About PECO Phillips Edison & Company Inc.

Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interest, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on a market of expertise designed to optimize property value and consistently deliver a great shopping experience.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: